Video: Productivity Suffers When Employees With Flu Go to Work
Posted on: Wednesday, 24 January 2007, 09:01 CST
NEWTOWN SQUARE, Pa., Jan. 24 /PRNewswire/ -- Flu season used to mean a loss of productivity in the workplace because of workers taking time off to recover, but now employers are facing sluggish productivity from ailing employees who insist on coming to work.
To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/boiron/26086/
"Presenteeism is a growing trend in the workplace where employees feel compelled to come to work despite the fact that they're sick," says Robin Rodin, a human resources expert based in Bryn Mawr, Pa. "This has significant impact on workplace productivity and can sacrifice performance goals."
Medical experts say if employees have to go to work sick with flu, then they should take a medicine that will relieve symptoms quickly without causing side effects, such as drowsiness, that further inhibit productivity. According to Dr. Robert Schiller, chairman of Family Medicine at Beth Israel Medical Center in New York City, one safe option is a homeopathic flu medicine, Oscillococcinum-Oscillo for short.
"Unlike other over-the-counter medications, Oscillo can significantly reduce the severity and duration of flu symptoms, such as body aches, fever and pain," says Dr. Schiller. "It doesn't have the side effects of drowsiness that can affect performance at work. It's safe for people from age two to seniors and has been supported by four clinical trials."
Oscillo, which is manufactured by Boiron, has a long history of safety and is regulated as a drug by the U.S. Food and Drug Administration.(1) Oscillo is widely available without a prescription in pharmacies and retailers nationwide. For more information, visit http://www.oscillo.com/ or call 1-800-BOIRON-1 (1-800-264-7661).
About Boiron:
Boiron, world leader in homeopathy, is a $500 million public company with more than 3,800 employees in over 60 countries. It produces more than 1,500 homeopathic medicines. For more than 70 years, Boiron has been committed to funding scientific research and educating the public and healthcare professionals on homeopathic medicines. As a pharmaceutical company, Boiron maintains the highest standards in manufacturing, complying with U.S. Food and Drug Administration regulations, the Homeopathic Pharmacopoeia of the U.S. and the Drug Good Manufacturing Practices.
1. US Food and Drug Administration, CPG 7132.15. Conditions Under Which a Homeopathic Drug May Be Marketed. Contact Info Deborah L. Kelly Public Relations Manager Boiron USA 610-325-8323 deborah.kelly@boiron.com
Video: http://www.prnewswire.com/mnr/boiron/26086
Boiron USA
CONTACT: Deborah L. Kelly, Public Relations Manager of Boiron USA,+1-610-325-8323, or deborah.kelly@boiron.com
Web site: http://www.boiron.com/
Source: PRNewswire
Related Articles
- Caterpillar Offers Retirement Incentive to Eligible Production Employees
- Caterpillar Announces Indefinite Layoffs for Production Employees at its Mossville, Illinois Engine Assembly Facility
- SXC Health Solutions Announces Contract Expansion With Arkansas' State and Public School Employees
- Canopus BioPharma's StatC Drug Shows Superior Results for Treatment of Avian Flu and Other Influenzas
- OMRIX Biopharmaceuticals Files Investigational New Drug (IND) Application For Anti-Adhesion Product Candidate and Announces Recent Milestone Achievements
- 'Grandma's a Drug Smuggler' Parody Released By Public-Interest Organization
- EU seeks to reassure public on bird flu
- S.D. Drug Firm Plans to Go Public
- Regional Health Officials Hold Press Conference to Urge Public Support of Flu Priority Guidelines
- Amgen Expands Drug Marketing Efforts to Promote Existing Products
User Comments (0)

RSS Feeds